Pr Laurent Greillier

Specialty

Oncologist, lung expert

Title

Head of department

Hospital

AP-HM Hôpital Nord (Marseille)

Latest articles

• Budigalimab: a viable option for patients with advanced solid tumors. (Aug 3, 2026)
• Development of an externally controlled trial from a single-arm study to assess first-line immunochemotherapy in advanced large cell neuroendocrine lung carcinomas: a study protocol from the FIRST-NEC GFPC 01-2022 trial. (Jul 29, 2026)
• First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors. (Jun 19, 2026)
• First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations. (May 29, 2026)
• Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors. (Apr 22, 2026)